Los Angeles-based aesthetic medicine developer KYTHERA Biopharmaceuticals announced today that it has named Frederick Beddingfield, III, as its Chief Medical Officer. Dr. Beddingfield is a dermatologist, who was most recently at Allergan, working on that firm's Botox, Juvederm, and Latisse products. The firm said Beddingfield will lead all clinical research and development, including strategy, operations, statistics, data management, medical writing, regulatory and quality for the company.
Top NewsWednesday, March 13, 2013
KYTHERA Names Chief Medical Officer